Clinical trials
Phase 1 Leukemia, Promyelocytic, Acute trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2004 | 2 |
| 2005 | 5 |
| 2006 | 3 |
| 2007 | 1 |
| 2009 | 4 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Terminated | 3 |
| Recruiting | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 12 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 6 |
| Case Comprehensive Cancer Center | 2 |
| M.D. Anderson Cancer Center | 2 |
| City of Hope Medical Center | 1 |
| Indiana University | 1 |
| Nohla Therapeutics, Inc. | 1 |
| Northwestern University | 1 |
| Orsenix LLC | 1 |
| Roswell Park Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Promyelocytic, Acute | 32 |
| Leukemia, Myeloid, Acute | 28 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 22 |
| Blast Crisis | 16 |
| Leukemia, Myelomonocytic, Acute | 16 |
| Leukemia, Erythroblastic, Acute | 13 |
| Leukemia, Megakaryoblastic, Acute | 13 |
| Leukemia, Monocytic, Acute | 13 |
| Congenital Abnormalities | 11 |
| Leukemia | 10 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.